Infusion of Lidocaine and Steroids in Middle Meningeal Artery for Pain in Subarachnoid Hemorrhage
Recruiting
Phase 2
Interventional Study
Subarachnoid Hemorrhage, Aneurysmal
Headache
Opiate Dependence
Opioid Use
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 – 100
- Sex
- Any
- Trial phase
- Phase 2
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 15 (estimated)
- Sponsor
- The University of Texas Medical Branch, Galveston · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to learn if an infusion of lidocaine, with or without steroids, into the middle meningeal artery (MMA) helps relieve severe headaches in patients with spontaneous subarachnoid hemorrhage (SAH). It will also study the safety of this treatment.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age ≥18 years.
* Diagnosed with aneurysmal SAH, Hunt and Hess Grades 1-2.
* Consent to study procedures and follow-up evaluations.
Exclusion Criteria:
* Known allergies to lidocaine or steroids.
* Arteriovenous malformations.
* Dural Arteriovenous Fistulas.
* Other significa…
Contacts